A detailed history of Rossmore Private Capital transactions in Novo Nordisk A S stock. As of the latest transaction made, Rossmore Private Capital holds 23,155 shares of NVO stock, worth $2.38 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
23,155
Previous 23,000 0.67%
Holding current value
$2.38 Million
Previous $3.28 Million 16.02%
% of portfolio
0.34%
Previous 0.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$119.07 - $145.42 $18,455 - $22,540
155 Added 0.67%
23,155 $2.76 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.05 Million - $2.29 Million
11,500 Added 100.0%
23,000 $2.09 Million
Q3 2018

Oct 26, 2018

BUY
$46.76 - $51.24 $537,740 - $589,260
11,500 New
11,500 $542,000
Q1 2018

May 04, 2018

SELL
$48.49 - $58.14 $20,850 - $25,000
-430 Closed
0 $0
Q4 2017

Mar 15, 2018

BUY
$47.53 - $53.73 $20,437 - $23,103
430
430 $23.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.